Mergers & Acquisitions ·
HeartSciences Inc. received a notice from Nasdaq on August 4, 2026, stating it is not in compliance with Listing Rule…
HSCSHeartSciences Inc.
HeartSciences Inc. received a notice from Nasdaq on August 4, 2026, stating it is not in compliance with Listing Rule 5550(b)(1) due to failing to maintain the required $2,500,000 minimum stockholders' equity. The company reported stockholders’ equity of only $226,060 as of April 30, 2026. Nasdaq has granted a 45-day period until September 18, 2026, to submit a compliance plan, with potential for an extension until January 31, 2027. The company intends to rely on the consummation of its proposed all-stock merger with Fortitude Mining Holdings, Inc., announced June 23, 2026, as the basis for regaining compliance. Failure to regain compliance could result in delisting, negatively impacting liquidity and financing capabilities. HeartSciences Inc. operates in the medical technology industry, developing minimally invasive treatments for heart failure.